GlyTherix
  • Home
  • Company
    • Management
    • Board
    • Clinical Advisory Panel
  • Product Pipeline
  • FAQs
  • News
  • Contact Us
Select Page

Industry News: MTPConnect’s COVID-19 Impact Report

by GlyTherix | Jun 17, 2020 | GlyTherix | 0 comments

MTP Industry News
  • Facebook
  • Twitter
  • LinkedIn

Explore the impact of the pandemic lockdown on medtech, biotech and pharma sectors in Australia by downloading MTPConnect’s  COVID-19 Impact Report.

Recent Posts

  • GlyTherix at JPM week
  • Celebrating Australian Radiopharmaceutical Innovation at AusBiotech 2025
  • GlyTherix Joins ARC Training Centre for Development of Advanced Radiochemical Technologies

RECENT POSTS

  • GlyTherix at JPM week
  • Celebrating Australian Radiopharmaceutical Innovation at AusBiotech 2025
  • GlyTherix Joins ARC Training Centre for Development of Advanced Radiochemical Technologies
  • GlyTherix & Isotopia Unite to Advance Radiopharmaceutical Innovation

ENQUIRIES

Address
Level 1, 3 Innovation Road,
Macquarie Park NSW 2113, Australia

Australian Business Number
66 621 291 996

MORE INFO

FOR SHAREHOLDERS:
Shareholder Communications Options

Would you like to talk with Glytherix about:

  • Investing in us?
  • Partnering with us?
  • Media events?
  • Some feedback?
  • Home
  • News
  • Terms of Use
  • Privacy Policy
  • Contact Us
  • LinkedIn

COPYRIGHT 2020 | GLYTHERIX - ALL RIGHTS RESERVED